Veda Trials Company Profile

Background

Overview

Veda Trials is a research enablement organization specializing in conducting high-quality, end-to-end clinical trial operations within community-based healthcare settings. By partnering with local providers, Veda aims to make clinical research more accessible, ensuring that transformative treatments reach a broader population efficiently and safely.

Mission and Vision

Veda's mission is to expand clinical research as a care option, bridging the gap between cutting-edge treatments and the patients who need them the most. The company envisions a future where clinical trials are seamlessly integrated into everyday care, enhancing patient outcomes and accelerating the development of new therapies.

Primary Area of Focus

Veda focuses on decentralizing clinical trials by enabling community-based clinics to conduct research. This approach addresses the challenge that 70% of patients live more than two hours away from the closest academic medical center, thereby reducing barriers to participation in clinical studies.

Industry Significance

By integrating clinical trials into local healthcare settings, Veda contributes to the evolution of decentralized clinical research, promoting diversity and inclusivity in study populations and expediting the delivery of new treatments to market.

Key Strategic Focus

Core Objectives

Expand Access: Increase the availability of clinical trials to underserved populations by partnering with community-based clinics.

Accelerate Enrollment: Streamline trial operations to expedite patient recruitment and reduce time-to-enrollment.

Maintain Quality: Ensure high standards of safety, data integrity, and regulatory compliance across all trials.

Specific Areas of Specialization

Therapeutic Areas: Specializes in allergy/asthma, dermatology, and women's health.

Trial Phases: Conducts both early and late-phase clinical trials.

Key Technologies Utilized

Low-Integration Technologies: Employs user-friendly platforms to minimize operational burden on local clinics.

Data Management Systems: Utilizes robust systems to ensure accurate and efficient data collection and analysis.

Primary Markets Targeted

Biopharmaceutical Companies: Seeking to broaden patient recruitment and reduce trial costs.

Contract Research Organizations (CROs): Looking to expand their reach into community settings.

Community-Based Healthcare Providers: Interested in offering clinical trial opportunities to their patients.

Financials and Funding

As of February 2026, specific details regarding Veda Trials' funding history, total funds raised, recent funding rounds, and notable investors are not publicly disclosed. The company has not publicly announced any funding rounds or disclosed financial information.

Pipeline Development

Veda Trials specializes in conducting clinical trials across various therapeutic areas, including allergy/asthma, dermatology, and women's health. The company partners with biopharmaceutical companies and CROs to identify and implement suitable clinical trials within community-based healthcare organizations. Specific details about pipeline candidates, stages of clinical trials, target conditions, and timelines for anticipated milestones are not publicly disclosed.

Technological Platform and Innovation

Proprietary Technologies

Trial Management Platforms: Developed to streamline site activation and study workflows, reducing operational burden for community clinics.

Significant Scientific Methods

Standard Operating Procedures (SOPs): Established to ensure consistent and high-quality trial execution across diverse sites.

Data Analytics: Employed to monitor trial progress and ensure data integrity.

AI-Driven Capabilities

Patient Recruitment Algorithms: Utilize data analytics to identify and recruit eligible patients efficiently.

Leadership Team

Lesley Solomon – Founder and CEO

Lesley Solomon founded Veda Trials with the vision to make clinical research accessible within community-based healthcare settings. Under her leadership, the company has developed partnerships with local providers and implemented technologies to streamline clinical trial operations.

Leadership Changes

In February 2026, Veda Trials was acquired by Lightship Inc., a modern clinical trial site organization. Following the acquisition, Lesley Solomon continues to serve as CEO, reporting to Lightship CEO David MacMurchy. This integration aims to expand community-based clinical research delivery across the United States.

Market Insights and Competitor Analysis

The decentralized clinical trial (DCT) market is experiencing significant growth, with projections estimating an increase from $10.7 billion in 2026 to over $21 billion by 2031. This expansion is driven by technological advancements and a regulatory push towards more inclusive and accessible clinical research models.

Key Competitors

Lightship Inc.: A direct competitor that has expanded its capabilities by acquiring Veda Trials, enhancing its community-based clinical research delivery.

MAPE Advisory Group Pvt. Ltd.: Operates in the investment banking and securities industry, focusing on financial advisory services.

Spark Capital: An investment company specializing in various financial services, including venture capital and private equity.

Intequant Advisors: Provides management consulting services, focusing on strategic and operational improvements for businesses.

Strategic Collaborations and Operational Insights

Veda Trials has established partnerships with local healthcare providers to integrate clinical trials into community settings. The recent acquisition by Lightship Inc. further strengthens its capabilities in community-based clinical research delivery.

Veda's decentralized approach allows for faster site activation and broader patient recruitment, thereby reducing operational costs and time-to-market for new therapies. The integration with Lightship Inc. is expected to enhance these operational efficiencies and expand the reach of clinical trials into more diverse populations.

Strategic Opportunities and Future Directions

The acquisition by Lightship Inc. positions Veda Trials to scale its community-based clinical research model nationally, offering more inclusive and efficient clinical trial operations. Future opportunities include expanding into additional therapeutic areas and further integrating technology to streamline trial processes.

Contact Information

Official Website: vedatrials.com

Note: As of February 2026, Veda Trials has been acquired by Lightship Inc., and the leadership team continues to operate under the new organizational structure.